NEWS DETAIL

FDA approves gedatolisib with fulvestrant, with or without palbociclib, for HR-positive, HER2-negative locally advanced or metastatic breast cancer

On July 14,2026, the Food and Drug Administration approved gedatolisib (Revtorpyk, Celcuity Inc.

July 15, 2026

该文章暂未提取到完整正文，已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。

Produits lies a cet article

Ces produits ont ete automatiquement associes au titre, au resume et au contenu de l article.

Questions frequentes

Which products are related to this article?

The system matched these relevant products from the article content: Lucius Pabocicni – Palbociclib – Acheter en ligne.

How can I view the medicines discussed in this article?

Use the related product cards below the article to review available specifications, prices, product information, and reviews.

Does this article replace advice from a doctor or pharmacist?

No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.